NCT06481683

Maternal Serum Stathmin-1 Levels in Preeclampsia

Evaluation of Maternal Serum Stathmin-1 Levels as a Biomarker in Preeclampsia and Severe Preeclampsia

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 80 (actual)
• Sponsor: Burak Yücel Special Clinic · Academic / Other
• Sex: Female
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

The goal of this observational study is to investigate maternal serum Stathmin-1 levels in pregnancies affected by preeclampsia compared to healthy gestations. The main questions it aims to answer are: 1. What are the maternal serum Stathmin-1 levels in pregnancies with preeclampsia? 2. How do Stathmin-1 levels differ between preeclampsia with severe features and uncomplicated pregnancies? Researchers will compare Stathmin-1 levels in pregnancies with preeclampsia and preeclampsia with severe features to those in a control group of healthy pregnancies to assess differences in biomarker levels. Participants will undergo blood sample collection at 32-34 weeks of gestation. Have their blood samples processed for Stathmin-1 level measurement using ELISA.

Conditions

• Preeclampsia

Timeline

• Start date: 2023-01-01
• Primary completion: 2023-07-01
• Completion: 2023-08-15
• First posted: 2024-07-01
• Last updated: 2024-09-19

Locations

1 site across 1 country: Turkey (Türkiye)